Haloperidol: Difference between revisions
>Josikins No edit summary |
>Sir Kibs |
||
Line 14: | Line 14: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | {{pharmacology}} | ||
As | As a typical antipsychotic, haloperidol has a diverse pharmacological profile. Primarily, haloperidol acts on [[dopamine]] D<sub>2</sub> [[receptor]]s as an [[antagonist]], as well as a D<sub>3</sub> inverse [[agonist]]. Haloperidol is also an antagonist of the [[serotonin |5-HT]]<sub>2A</sub> receptor, although this effect is not as powerful as that of [[quetiapine]]. Unlike many antipsychotcs, haloperidol has negligible affinity for the muscarinic acetylcholine receptors as well as the histamine receptors, which results in less sedation, weight gain and hypotension.<ref>H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs | http://www.nature.com/npp/journal/v28/n3/full/1300027a.html</ref> | ||
==Subjective effects== | ==Subjective effects== |